# Paul J. Ross

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/paul-j-ross/

## Facts

| Field | Value |
| --- | --- |
| Citations | 24,101 |
| Field | Hepatocellular Carcinoma Treatment and Prognosis |
| h-index | 62 |
| i10-index | 152 |
| Last Known Institution | Guy's and St Thomas' NHS Foundation Trust |
| OpenAlex ID | https://openalex.org/A5084034524 |
| ORCID iD | https://orcid.org/0000-0002-2390-1886 |
| Works | 393 |

## Researcher papers

- [Second-line FOLFOX chemotherapy versus active symptom control for advanced biliary tract cancer (ABC-06): a phase 3, open-label, randomised, controlled trial](https://scholariq.org/papers/second-line-folfox-chemotherapy-versus-active-symptom-control-for-advanced/)
- [First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global): a combined analysis of three multicentre, randomised, phase 3 trials](https://scholariq.org/papers/first-line-selective-internal-radiotherapy-plus-chemotherapy-versus-chemotherapy/)

## Researcher topics

- [Hepatocellular Carcinoma Treatment and Prognosis](https://scholariq.org/topics/hepatocellular-carcinoma-treatment-and-prognosis/)
- [Colorectal Cancer Treatments and Studies](https://scholariq.org/topics/colorectal-cancer-treatments-and-studies/)
- [Renal cell carcinoma treatment](https://scholariq.org/topics/renal-cell-carcinoma-treatment/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Pancreatic and Hepatic Oncology Research](https://scholariq.org/topics/pancreatic-and-hepatic-oncology-research/)

## Researcher university

- [Guy's and St Thomas' NHS Foundation Trust](https://scholariq.org/institutions/guy-s-and-st-thomas-nhs-foundation-trust/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.